States are beginning to limit what patients pay out of pocket for expensive specialty drugs that treat serious, chronic diseases such as rheumatoid arthritis and multiple sclerosis. By Michael Ollove Stateline As more expensive specialty drugs come on the market to treat some of the most serious chronic diseases, more states are stepping in to […]
